Staphylococcus and Neisseria Tablets(Qilu Pharma)

白葡奈氏菌片（齐鲁制药）

Report date: 2026/03/12 20:00:16

Base Information

Drug NameStaphylococcus and Neisseria Tablets(Qilu Pharma)
Drug Alias Namestaphylococcus albicans气管炎菌苗片Staphylococcus and Neisseria气片
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisRespiratory Tract Diseases +[5] 
Global Approved IndicationsRespiratory Tract DiseasesTracheitisBronchitis, Chronic
Approved Indications in ChinaRespiratory Tract DiseasesTracheitisBronchitis, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date1993/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co LtdQianfoshan Hospital, Shandong Province
Inactive CompaniesXiamen Hospital, Zhongshan Hospital Affiliated To Fudan University
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisTracheitis +[4] 
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A